Medicinska fakulteten

Organisation: fakultet

Fler filtreringsmöjligheter
  1. Tumor Biological Features of BRCA1-Induced Breast Cancer

    Johannsson, O. T., Idvall, I., Andersson, C., Åke Borg, Barkardóttir, R. B., Egilsson, V. & Håkan Olsson, 1997, I : European Journal of Cancer. 33, 3, s. 362-371

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Tumor blood flow in rats measured by labelled microspheres. Influence of catechol amines and the relation to adrenergic innervation of the tumor.

    Sundqvist, K., Hafström, L., Nobin, A. & B. Persson, 1979 jan 1, I : Bibliotheca anatomica. 18, s. 213-216 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Tumor characteristics and prognosis in women with pregnancy-associated breast cancer

    Johansson, A. L. V., Andersson, T. M. L., Hsieh, C. C., Karin Jirström, Cnattingius, S., Fredriksson, I., Dickman, P. W. & Lambe, M., 2018, I : International Journal of Cancer. 142, 7, s. 1343-1354

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy

    van der Most, R. G., Currie, A. J., Mahendran, S., Prosser, A., Anna Darabi, Robinson, B. W. S., Nowak, A. K. & Lake, R. A., 2009, I : Cancer Immunology and Immunotherapy. 58, 8, s. 1219-1228

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer

    Lagerstedt-Robinson, K., Johan Staaf, Göran Jönsson, Hansson, E., Lönnroth, C., Kressner, U., Lindström, L., Nordgren, S., Åke Borg & Lundholm, K., 2007 okt 12, I : Cancer Informatics. 3, s. 341-55 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

    Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Buerger, H., Agelopoulos, K., Myklebost, O., Serra, M., Fredrik Mertens, Hogendoom, P. C. W., Lankester, A. C. & Cleton-Jansen, A-M., 2011, I : Clinical Cancer Research. 17, 8, s. 2110-2119

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage-Activating Agents

    Buddingh, E. P., Kuijjer, M. L., Duim, R., Burger, H., Agelopoulos, K., Myklebost, O., Serra, M., Fredrik Mertens, Hogendoorn, P. C. W., Lankester, A. C. & Cleton-Jansen, A-M., 2011, I : Laboratory Investigation. 91, Feb 26 - Mar 4, 2011, s. 10A

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  8. Tumor-initiating cells in childhood neuroblastoma: Letter

    Sofie Mohlin, Alexander Pietras, Wigerup, C., Ingrid Øra, Andäng, M., Nilsson, K., Olofsson, T., David Gisselsson Nord & Sven Påhlman, 2012, I : Cancer Research. 72, 3, s. 821-822

    Forskningsoutput: TidskriftsbidragLetter

  9. Tumor karyotype predicts clinical outcome in colorectal cancer patients

    Bardi, G., Fenger, C., Bertil Johansson, Felix Mitelman & Heim, S., 2004, I : Journal of Clinical Oncology. 22, 13, s. 2623-2634

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes

    Kari Hemminki, Santi, I., Weires, M., Thomsen, H., Jan Sundquist & Bermejo, J. L., 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Tumor markers in prostate cancer I: Blood-based markers

    Shariat, S. F., Semjonow, A., Hans Lilja, Savage, C., Vickers, A. J. & Anders Bjartell, 2011, I : Acta Oncologica. 50, s. 61-75

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  12. Tumor Necrosis Factor-alpha as a target cytokine in vascular disease

    Brånén, L., 2004, Lena Brånén, Exp. Cardiovasc. Res, Wallenberg Lab, Entrance 46, Fl 1, 205 02 Malmö,. 107 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  13. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.

    Öhman, J., Nordin Fredrikson, G., Lisa Berglund, Gustavsson, C., Eva Bengtsson, Smith, M-L., Agardh, C-D., Elisabet Agardh, Jovinge, S., Maria Gomez & Jan Nilsson, 2009, I : Arteriosclerosis, Thrombosis and Vascular Biology. 29, 10, s. 1465-1470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Tumor necrosis factor and its receptors in the neuroretina and retinal vasculature after ischemia-reperfusion injury in the pig retina.

    Bodil Gesslein, Håkansson, G., Gustafsson, L., Per Ekström & Malin Malmsjö, 2010, I : Molecular Vision. 16, s. 2317-2327

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis A nationwide population-based cohort study

    Raaschou, P., Söderling, J., Carl Turesson, Askling, J. & ARTIS Study Group, 2018 sep 4, I : Annals of Internal Medicine. 169, 5, s. 291-299 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Tumor Necrosis Factor Receptor 1 and 2 Are Associated With Risk of Intracerebral Hemorrhage

    Edith H. Svensson, Martin Söderholm, Kasim Abul-Kasim & Gunnar Engström, 2017 okt 1, I : Stroke. 48, 10, s. 2710-2715 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis.

    Iosif, R., Ekdahl, C. T., Henrik Ahlenius, Pronk, C. J. H., Bonde, S., Zaal Kokaia, Jacobsen, S. E. W. & Olle Lindvall, 2006, I : Journal of Neuroscience. 26, 38, s. 9703-9712

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors.

    Kees-Jan Pronk, Veiby, O. P., David Bryder & Jacobsen, S. E. W., 2011, I : Journal of Experimental Medicine. 208, 8, s. 1563-1570

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells

    Dybedal, I., David Bryder, Fossum, A., Rusten, L. S. & Jacobsen, S. E. W., 2001, I : Blood. 98, 6, s. 1782-1791

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    Zardavas, D., Te Marvelde, L., Milne, R. L., Fumagalli, D., Fountzilas, G., Kotoula, V., Razis, E., Papaxoinis, G., Joensuu, H., Moynahan, M. E., Hennessy, B. T., Bieche, I., Saal, L. H., Stal, O., Iacopetta, B., Jensen, J. D., O'Toole, S., Lopez-Knowles, E., Barbaraeschi, M., Noguchi, S. & 12 andra, Azim, H. A., Lerma, E., Bachelot, T., Wang, Q., Perez-Tenorio, G., Can De Velde, C. J. H., Rea, D. W., Sabine, V., Bartlett, J. M. S., Sotiriou, C., Michiels, S. & Loi, S., 2018 jan 1, I : Journal of Clinical Oncology. 36, 10, s. 981-990 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift